vs
Side-by-side financial comparison of NICOLET BANKSHARES INC (NIC) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
NICOLET BANKSHARES INC is the larger business by last-quarter revenue ($104.0M vs $57.3M, roughly 1.8× RHYTHM PHARMACEUTICALS, INC.). NICOLET BANKSHARES INC runs the higher net margin — 38.8% vs -83.0%, a 121.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 12.5%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 12.5%).
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
NIC vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.0M | $57.3M |
| Net Profit | $40.3M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 48.3% | -82.2% |
| Net Margin | 38.8% | -83.0% |
| Revenue YoY | 12.5% | 36.9% |
| Net Profit YoY | 16.9% | -9.6% |
| EPS (diluted) | $2.63 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $104.0M | $57.3M | ||
| Q3 25 | $102.9M | $51.3M | ||
| Q2 25 | $95.7M | $48.5M | ||
| Q1 25 | $89.4M | $32.7M | ||
| Q4 24 | $92.4M | $41.8M | ||
| Q3 24 | $90.7M | $33.3M | ||
| Q2 24 | $85.0M | $29.1M | ||
| Q1 24 | $82.2M | $26.0M |
| Q4 25 | $40.3M | $-47.5M | ||
| Q3 25 | $41.7M | $-52.9M | ||
| Q2 25 | $36.0M | $-46.6M | ||
| Q1 25 | $32.6M | $-49.5M | ||
| Q4 24 | $34.5M | $-43.3M | ||
| Q3 24 | $32.5M | $-43.6M | ||
| Q2 24 | $29.3M | $-32.3M | ||
| Q1 24 | $27.8M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | 48.3% | -82.2% | ||
| Q3 25 | 50.4% | -102.6% | ||
| Q2 25 | 46.8% | -93.4% | ||
| Q1 25 | 44.9% | -143.7% | ||
| Q4 24 | 46.8% | -98.6% | ||
| Q3 24 | 45.0% | -132.0% | ||
| Q2 24 | 43.3% | -139.2% | ||
| Q1 24 | 41.8% | -538.7% |
| Q4 25 | 38.8% | -83.0% | ||
| Q3 25 | 40.6% | -103.1% | ||
| Q2 25 | 37.6% | -96.1% | ||
| Q1 25 | 36.4% | -151.4% | ||
| Q4 24 | 37.3% | -103.6% | ||
| Q3 24 | 35.8% | -131.2% | ||
| Q2 24 | 34.5% | -110.9% | ||
| Q1 24 | 33.8% | -544.4% |
| Q4 25 | $2.63 | $-0.73 | ||
| Q3 25 | $2.73 | $-0.82 | ||
| Q2 25 | $2.34 | $-0.75 | ||
| Q1 25 | $2.08 | $-0.81 | ||
| Q4 24 | $2.21 | $-0.71 | ||
| Q3 24 | $2.10 | $-0.73 | ||
| Q2 24 | $1.92 | $-0.55 | ||
| Q1 24 | $1.82 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $388.9M |
| Total DebtLower is stronger | $134.9M | — |
| Stockholders' EquityBook value | $1.3B | $139.1M |
| Total Assets | $9.2B | $480.2M |
| Debt / EquityLower = less leverage | 0.11× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | — | $319.1M | ||
| Q1 24 | — | $201.2M |
| Q4 25 | $134.9M | — | ||
| Q3 25 | $134.6M | — | ||
| Q2 25 | $134.3M | — | ||
| Q1 25 | $156.6M | — | ||
| Q4 24 | $161.4M | — | ||
| Q3 24 | $161.2M | — | ||
| Q2 24 | $162.4M | — | ||
| Q1 24 | $162.3M | — |
| Q4 25 | $1.3B | $139.1M | ||
| Q3 25 | $1.2B | $148.8M | ||
| Q2 25 | $1.2B | $-11.9M | ||
| Q1 25 | $1.2B | $18.9M | ||
| Q4 24 | $1.2B | $21.7M | ||
| Q3 24 | $1.1B | $11.2M | ||
| Q2 24 | $1.1B | $39.3M | ||
| Q1 24 | $1.1B | $61.6M |
| Q4 25 | $9.2B | $480.2M | ||
| Q3 25 | $9.0B | $506.9M | ||
| Q2 25 | $8.9B | $372.7M | ||
| Q1 25 | $9.0B | $386.7M | ||
| Q4 24 | $8.8B | $392.3M | ||
| Q3 24 | $8.6B | $363.6M | ||
| Q2 24 | $8.6B | $381.8M | ||
| Q1 24 | $8.4B | $258.7M |
| Q4 25 | 0.11× | — | ||
| Q3 25 | 0.11× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.15× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $153.5M | $-25.4M |
| Free Cash FlowOCF − Capex | $149.4M | — |
| FCF MarginFCF / Revenue | 143.7% | — |
| Capex IntensityCapex / Revenue | 3.9% | — |
| Cash ConversionOCF / Net Profit | 3.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | $275.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $153.5M | $-25.4M | ||
| Q3 25 | $45.9M | $-26.6M | ||
| Q2 25 | $38.9M | $-23.3M | ||
| Q1 25 | $41.8M | $-40.4M | ||
| Q4 24 | $133.7M | $-18.8M | ||
| Q3 24 | $39.6M | $-25.2M | ||
| Q2 24 | $37.3M | $-29.1M | ||
| Q1 24 | $23.4M | $-40.7M |
| Q4 25 | $149.4M | — | ||
| Q3 25 | $45.9M | — | ||
| Q2 25 | $38.4M | — | ||
| Q1 25 | $41.3M | — | ||
| Q4 24 | $116.8M | — | ||
| Q3 24 | $34.7M | — | ||
| Q2 24 | $34.4M | — | ||
| Q1 24 | $20.1M | — |
| Q4 25 | 143.7% | — | ||
| Q3 25 | 44.6% | — | ||
| Q2 25 | 40.1% | — | ||
| Q1 25 | 46.2% | — | ||
| Q4 24 | 126.4% | — | ||
| Q3 24 | 38.3% | — | ||
| Q2 24 | 40.5% | — | ||
| Q1 24 | 24.4% | — |
| Q4 25 | 3.9% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 18.3% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 4.0% | — |
| Q4 25 | 3.81× | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 1.08× | — | ||
| Q1 25 | 1.28× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | 1.22× | — | ||
| Q2 24 | 1.28× | — | ||
| Q1 24 | 0.84× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
